日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacological blockade of the mast cell MRGPRX2 receptor supports investigation of its relevance in skin disorders.

药理学阻断肥大细胞 MRGPRX2 受体有助于研究其在皮肤疾病中的相关性

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1433982
Macphee Colin H, Dong Xinzhong, Peng Qi, Paone Daniel V, Skov Per Stahl, Baumann Katrine, Roethke Theresa, Goldspink Deborah A, Pearson Samuel K, Wu Zining
细胞生物学
发表日期：2024
文献求助 收藏

Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events

糖尿病状态会影响脂蛋白相关磷脂酶A2对主要冠状动脉事件的长期影响。

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-021-05574-5
Siddiqui, Moneeza K; Smith, Gillian; St Jean, Pamela; Dawed, Adem Y; Bell, Samira; Soto-Pedre, Enrique; Kennedy, Gwen; Carr, Fiona; Wallentin, Lars; White, Harvey; Macphee, Colin H; Waterworth, Dawn; Palmer, Colin N A
糖尿病
代谢
发表日期：2022
文献求助 收藏

Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial

达拉普拉地治疗对颈动脉内膜剥脱术后斑块脂蛋白相关磷脂酶A2活性的影响：一项随机对照试验

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0089034
Johnson, Joel L; Shi, Yi; Snipes, Rose; Janmohamed, Salim; Rolfe, Timothy E; Davis, Bill; Postle, Anthony; Macphee, Colin H
发表日期：2014
文献求助 收藏

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

抑制脂蛋白相关磷脂酶A2可减少复杂冠状动脉粥样硬化斑块的形成。

期刊:Nature Medicine
影响因子:50
doi:10.1038/nm.1870
Wilensky, Robert L; Shi, Yi; Mohler, Emile R 3rd; Hamamdzic, Damir; Burgert, Mark E; Li, Jun; Postle, Anthony; Fenning, Robert S; Bollinger, James G; Hoffman, Bryan E; Pelchovitz, Daniel J; Yang, Jisheng; Mirabile, Rosanna C; Webb, Christine L; Zhang, LeFeng; Zhang, Ping; Gelb, Michael H; Walker, Max C; Zalewski, Andrew; Macphee, Colin H
心血管
动脉粥样硬化
发表日期：2008
文献求助 收藏